Race and hormone receptor–positive breast cancer outcomes in a randomized chemotherapy trial

JA Sparano, M Wang, F Zhao, V Stearns… - Journal of the …, 2012 - academic.oup.com
Background The association between black race and worse outcomes in operable breast
cancer reported in previous studies has been attributed to a higher incidence of more …

Outcomes of hormone-receptor positive, HER2-negative breast cancers by race and tumor biological features

HC Benefield, KE Reeder-Hayes… - JNCI cancer …, 2021 - academic.oup.com
Background Black women have higher hormone receptor positive (HR+) breast cancer
mortality than White women. Early recurrence rates differ by race, but little is known about …

Race, response to chemotherapy, and outcome within clinical breast cancer subtypes

JR Tichy, AM Deal, CK Anders… - Breast cancer research …, 2015 - Springer
The effect of race on breast cancer outcome is confounded by tumor and treatment
heterogeneity. We examined a cohort of women with stage II–III breast cancer treated …

Race, ethnicity, and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial

KS Albain, RJ Gray, DF Makower… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Black race is associated with worse outcomes in early breast cancer. We
evaluated clinicopathologic characteristics, the 21-gene recurrence score (RS), treatment …

Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities

GH Rauscher, A Silva, H Pauls, J Frasor… - Breast cancer research …, 2017 - Springer
Abstract Introduction Non-Latina black breast cancer patients experience a shorter survival
from breast cancer than their non-Latina white counterparts. We compared breast cancer …

Racial disparities in survival outcomes among breast cancer patients by molecular subtypes

F Zhao, B Copley, Q Niu, F Liu, JA Johnson… - Breast cancer research …, 2021 - Springer
Purpose Differences in tumor biology, genomic architecture, and health care delivery
patterns contribute to the breast cancer mortality gap between White and Black patients in …

Adherence to endocrine therapy and racial outcome disparities in breast cancer

KE Reeder-Hayes, MA Troester, SB Wheeler - The Oncologist, 2021 - academic.oup.com
The disparity in outcomes of breast cancer for Black compared with White women in the US
is well known and persistent over time, with the largest disparities appearing among women …

Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors

ET Warner, RM Tamimi, ME Hughes… - Journal of clinical …, 2015 - ascopubs.org
Purpose To evaluate the relationship between race/ethnicity and breast cancer–specific
survival according to subtype and explore mediating factors. Patients and Methods …

Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis

AK Green, EM Aviki, K Matsoukas, S Patil… - Breast cancer research …, 2018 - Springer
Purpose We conducted a systematic review and meta-analysis to measure the extent to
which race is associated with delayed initiation or receipt of inadequate chemotherapy …

Racial disparities in treatment and survival of male breast cancer

KD Crew, AI Neugut, X Wang, JS Jacobson… - Journal of clinical …, 2007 - ascopubs.org
Purpose Black women with breast cancer have poorer survival than do white women, but
little is known about racial disparities in male breast cancer. We analyzed race and other …